Retail investors of GeneOne Life Sciences said the company was losing its credibility because it failed to meet the Covid-19 pipeline development schedule and its contract manufacturing organization (CMO) sales target.In November 2021, the company announced a capital increase of about 113.8 billion
JW Group said on Tuesday that it signed a joint research contract with Kure.AI Therapeutics, a U.S. bio-venture company, to develop innovative anticancer drugs based on artificial intelligence (AI).Under the agreemment, JW Pharmaceutical and JW CreaGene will start research and development of three n
ST Pharm’s operating profit declined somewhat in the third quarter, drawing the industry's attention.In a public notice, the company said it recorded sales of 60.8 billion won ($42.7 million) and a net profit of 9.9 billion based on the consolidated balance sheet in the July-September quarter.They m
Opdivo (nivolumab), anti-PD-1 immunotherapy co-developed by Ono Pharmaceutical and BMS, has taken its first step as a complete recovery partner for early non-small cell lung cancer (NSCLC) patients in Korea.Last Wednesday, the Ministry of Food and Drug Safety approved the combined administration of
BMS Pharmaceutical Korea has obtained permission for a series of blood cancer treatments this year, increasing its weight in the domestic market.Starting with a nod for the treatment of acute myeloid leukemia, Onureg (azacitidine), in March, it obtained approvals for Inreㅠic (pedratinib), a treatmen
Ferring Pharmaceuticals' recent decision to suspend global shipments of Menopur, an infertility treatment, is likely to bring a shortage of the drug in Korea, officials said.The news comes after Business Insider reported that Elizabeth Garner, Ferring's chief science officer, reportedly sent out an
An Israeli health expert said preventing 19A serotype was an important factor to consider when using pediatric pneumococcal vaccines.Pfizer Korea invited Professor Ron Dagan of Pediatrics and Infectious Diseases at the Ben-Gurion University to speak on the latest regional epidemiological data on pne
OliPass, a Korean company specializing in RNA treatment platform, received an upfront fee of $3 million (4.3 billion won) from Vanda Pharmaceuticals, a U.S. biopharmaceutical company, regarding a joint research and development contract for a new RNA-based treatment.On Sept. 29, the two companies sig
Hugel said the U.S. Food and Drug Administration (FDA) started reviewing its biologics license application (BLA) for Letybo (brand name in Korea: Botulax), its botulinum toxin (BTX) formulation, to treat forehead wrinkles on Tuesday.This is the second time that Hugel filed a BLA for Letybo to the FD
Huons Global said it has signed a memorandum of understanding (MOU) with Lotte Biologics for conducting clinical trials and producing new drug candidates .Under the contract, Huons Global will manufacture and produce investigational biopharmaceuticals at Bristol-Myers Squibb (BMS)’s U.S. plant in Sy
Pharmbio Korea said on Thursday that its Orafang tablet, taken for bowel preparation before colonoscopy, has won a patent in the U.S.Accordingly, the pill developed with domestic technology will be guaranteed exclusive rights to technologies related to the same formulation in the U.S. until May 27,
MSD Korea is strengthening its position in the local antibiotic market with Zerbaxa (ingredient: ceftolozane/tazobactam) after winning reimbursement for the new drug on Oct. 1."Currently, antibiotic resistance is one of the most serious health problems in the world," Professor Choo Eun-joo of the De
HK inno.N is speeding up the launch of a "low-capacity K-CAB tablet," which reduced capacity compared to existing K-cap tablets.The company said Wednesday that it would release "K-CAB tablet 25mg,” which halved the capacity of K-CAB tablet 50mg, next year.K-CAB (tegoprazan) is a new potassium compet
Customized treatment for cancer patients has become possible with the development of immunotherapies.However, Korea’s outdated reimbursement for pathology tests, a prerequisite for using immunotherapy, has become a stumbling block for faster anticancer treatment, pathologists and oncologists said at
SK Bioscience said on Thursday that it signed a memorandum of understanding (MOU) for joint research and development of new vaccines and platforms with Hilleman Laboratories, an international non-profit research institute.Hilleman Laboratories is a research institute established in 2009 by a joint v
AstraZeneca Korea and Abbott said they would collaborate to provide a more systemic treatment and management of diabetic kidney disease in Korea.The Korean unit of AstraZeneca and Abbott Rapid Diagnostics Korea signed a partnership agreement to improve the treatment environment for diabetic kidney d
Introducing immunotherapy Libtayo (cemiplimab-rwlc) in Korea, Sanofi has selected cutaneous squamous cell carcinoma (cSCC) as its primary indication, for which there are no competitive products.According to a domestic skin cancer epidemiological study published early this year, the incidence of cSCC
Boryung said that it has acquired all local rights, including sales and licensing, concerning Lilly's non-small cell lung cancer (NSCLC) Alimta (ingredient: pemetrexed) for $70 million.Alimta is the third drug Boryung bought from Lilly, following the acquisition of Gemzar, an anticancer drug treatin
Shinpoong Pharmaceutical said it was redesigning the phase 1 clinical trial of SP-8356, a treatment for intractable cardiovascular disease, in the U.K.According to ClinicalTrials.gov, a clinical information site of the U.S. National Institutes of Health (NIH), Shinpoong Pharmaceutical terminated the
SK Bioscience plans to work with Coalition for Epidemic Preparedness Innovations (CEPI) to secure mRNA vaccine platform technology to quickly respond to infectious diseases and use it to secure a diverse vaccine portfolio.To respond to Disease X swiftly and solve the problem of vaccine supply imbala